Kawasaki, Japan

Hiroshi Umishio

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Ajinomoto Co., Ltd.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Umishio. Retrieved from https://idiyas.com/inventor/hiroshi-umishio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroshi Umishio: Innovator in Immunostimulation

Introduction

Hiroshi Umishio is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of immunology, particularly through his innovative work on immunostimulating agents. His research focuses on compounds that enhance immune responses, which are crucial for developing effective vaccines.

Latest Patents

Hiroshi Umishio holds a patent for an immunostimulating agent. The patent describes compounds represented by a specific formula that exhibit immunostimulatory effects. These compounds are particularly useful as adjuvants and in compositions containing antigens for vaccines.

Career Highlights

Umishio is associated with Ajinomoto Co., Ltd., a company known for its advancements in food and biotechnology. His work at Ajinomoto has allowed him to explore the intersection of nutrition and immunology, leading to innovative solutions in health and wellness.

Collaborations

Throughout his career, Hiroshi Umishio has collaborated with esteemed colleagues such as Shigekazu Kurihara and Kenji Tanaka. These partnerships have fostered a collaborative environment that enhances research and development in immunostimulation.

Conclusion

Hiroshi Umishio's contributions to immunology through his patent and work at Ajinomoto Co., Ltd. highlight his role as an innovator in the field. His research continues to pave the way for advancements in vaccine development and immune health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…